Click here to subscribe to Biomedical Materials and immediately access all its archives
Click here to review the contents of the November 2009 issue of Biomedical Materials and download it online
Issue: November 2009, page: 7
ReGen continues to back knee implant, while US authority reviews own procedures
ReGen Biologics is continuing to market its collagen meniscus implant, trademarked Menaflex, while the US Food and Drug Administration (FDA) reviews its procedural assessment of the process by which the implant received marketing clearance.
